Biomedical research: synthetic data overcome GDPR limits - Agenda Digitale

▤ Summary

This article explains how synthetic data can help biomedical research overcome GDPR limits without sacrificing analytical value. It contrasts the privacy and utility tradeoffs of anonymization and pseudonymization with generative AI approaches that preserve statistical structure while reducing personal-data exposure. It also highlights use cases in oncology, rare diseases, and synthetic external control arms for clinical trials. The piece notes that European and Italian regulatory developments could speed adoption, but current legal uncertainty still slows implementation and investment.

▦ Linked Companies